These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28790859)

  • 21. Excess accumulation of body fat is related to dyslipidemia in normal-weight subjects.
    Ito H; Nakasuga K; Ohshima A; Sakai Y; Maruyama T; Kaji Y; Harada M; Jingu S; Sakamoto M
    Int J Obes Relat Metab Disord; 2004 Feb; 28(2):242-7. PubMed ID: 14610531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of dyslipidemia and associated risk factors among rural Chinese adults.
    Sun GZ; Li Z; Guo L; Zhou Y; Yang HM; Sun YX
    Lipids Health Dis; 2014 Dec; 13():189. PubMed ID: 25496459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impacts of types and degree of obesity on non-alcoholic fatty liver disease and related dyslipidemia in Chinese school-age children?
    Meng L; Luo N; Mi J
    Biomed Environ Sci; 2011 Feb; 24(1):22-30. PubMed ID: 21440836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of laparoscopic sleeve gastrectomy on insulin secretion patterns in morbidly obese patients].
    Qian C; Zhu C; Gao J; Bu L; Zhou D; Li N; Qu S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):61-67. PubMed ID: 29354901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance profile among siblings of type 2 diabetes mellitus (preliminary study).
    Purnamasari D; Soegondo S; Oemardi M; Gumiwang I
    Acta Med Indones; 2010 Oct; 42(4):204-8. PubMed ID: 21063041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of dyslipidemia associated with complications in diabetic patients: a nationwide study in Thailand.
    Narindrarangkura P; Bosl W; Rangsin R; Hatthachote P
    Lipids Health Dis; 2019 Apr; 18(1):90. PubMed ID: 30954084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence, patterns, and associations of dyslipidemia among Sri Lankan adults-Sri Lanka Diabetes and Cardiovascular Study in 2005-2006.
    Katulanda P; Dissanayake HA; De Silva SDN; Katulanda GW; Liyanage IK; Constantine GR; Sheriff R; Matthews DR
    J Clin Lipidol; 2018; 12(2):447-454. PubMed ID: 29429894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum vitamin E as a significant prognostic factor in patients with dyslipidemia disorders.
    Barzegar-Amini M; Ghazizadeh H; Seyedi SMR; Sadeghnia HR; Mohammadi A; Hassanzade-Daloee M; Barati E; Kharazmi-Khorassani S; Kharazmi-Khorassani J; Mohammadi-Bajgiran M; Tavallaie S; Ferns GA; Mouhebati M; Ebrahimi M; Tayefi M; Ghayour-Mobarhan M
    Diabetes Metab Syndr; 2019; 13(1):666-671. PubMed ID: 30641786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic syndrome and associated factors among psychiatric patients in Jimma University Specialized Hospital, South West Ethiopia.
    Asaye S; Bekele S; Tolessa D; Cheneke W
    Diabetes Metab Syndr; 2018 Sep; 12(5):753-760. PubMed ID: 29729979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid profile and dyslipidemia among school-age children in urban Ghana.
    Lartey A; Marquis GS; Aryeetey R; Nti H
    BMC Public Health; 2018 Mar; 18(1):320. PubMed ID: 29510714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.
    Gonzélez C; Stern MP; Mitchell BD; Valdez RA; Haffner SM; Pérez BA
    Diabetes Care; 1994 May; 17(5):397-404. PubMed ID: 8062606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Association of insulin resistance with dyslipidemia in adults with type 1 diabetes].
    Luo SH; Yang DZ; Wei XY; Ai HY; Lin QY; Liu ZY; Ling P; Lü J; Yan JH; Yao B; Weng JP; Zheng XY
    Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(34):2665-2669. PubMed ID: 31505716
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of diabetic dyslipoproteinemia.
    Steinmetz A
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):239-45. PubMed ID: 12951627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-hyperglycemic and hypolipidemic effects of Cistanche tubulosa in type 2 diabetic db/db mice.
    Xiong WT; Gu L; Wang C; Sun HX; Liu X
    J Ethnopharmacol; 2013 Dec; 150(3):935-45. PubMed ID: 24095831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between anthropometric parameters and lipid profiles in Chinese individuals with age ≥40 years and BMI <28kg/m2.
    Yang Z; Ding X; Liu J; Duan P; Si L; Wan B; Tu P
    PLoS One; 2017; 12(6):e0178343. PubMed ID: 28632766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of dyslipidemia and metabolic syndrome risk factor in overweight and obese children.
    Casavalle PL; Lifshitz F; Romano LS; Pandolfo M; Caamaño A; Boyer PM; Rodríguez PN; Friedman SM
    Pediatr Endocrinol Rev; 2014 Dec; 12(2):213-23. PubMed ID: 25581987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dyslipidemias in type 2 diabetes mellitus patients in Nnewi South-East Nigeria.
    Jisieike-Onuigbo NN; Unuigbe EI; Oguejiofor CO
    Ann Afr Med; 2011; 10(4):285-9. PubMed ID: 22064254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dyslipidemia in outpatients at General Hospital in Kumasi, Ghana: cross-sectional study.
    Eghan BA; Acheampong JW
    Croat Med J; 2003 Oct; 44(5):576-8. PubMed ID: 14515416
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.